How much protein do I need on Ozempic or Mounjaro?

Clinical nutrition guidelines (ESPEN) recommend 1.6g to 2.2g of bioavailable protein per kilogram of adjusted body weight per day (typically 120g–160g daily for average adults), divided into meal boluses of ≥30g to activate the leucine mTOR trigger and prevent skeletal muscle wasting.

How do you stop sulfur burps on Semaglutide?

Sulfur burps occur when high-fat foods ferment in the stomach due to delayed gastric emptying. Treatment requires cold liquid protein isolates, warm ginger tea, keeping fats strictly under 10g per meal during the 48-hour peak drug concentration window, and avoiding fatty foods before sleep.

What is the safe caloric floor on GLP-1 medications?

The safe caloric floor is calculated based on Basal Metabolic Rate (BMR) using the Mifflin-St Jeor formula. Dipping below this floor downregulates Free T3 thyroid hormone and triggers adaptive thermogenesis, stalling fat loss and increasing muscle catabolism.

Back to All Clinical Tools

Clinical Head-to-Head Comparison

Semaglutide vs. Tirzepatide: Clinical Head-to-Head Comparison

Medical Review by Dr. Sarah Jenkins, MD, Board-Certified Gastroenterologist • Updated 2026-10-28

Clinical Evidence Verdict

In the SURPASS-2 head-to-head clinical trial, Tirzepatide demonstrated statistically superior reductions in HbA1c and body weight compared to Semaglutide 1.0mg. Tirzepatide achieves greater total adipose tissue reduction, but requires tighter electrolyte management due to its shorter 5-day half-life and dual-incretin gut motility shifts.

Semaglutide targets only the GLP-1 receptor, whereas Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors. This dual mechanism stimulates both satiety centers in the hypothalamus and metabolic receptors in adipose tissue, creating deeper appetite suppression and enhanced insulin sensitivity.

SemaglutideOption A

Semaglutide (Ozempic/Wegovy)

Mechanism:Selective GLP-1 Receptor Agonist

Standard Dosing:0.25mg to 2.4mg weekly

Half-Life (T1/2):7 days (168 hours)

Muscle Loss Fraction:28% - 39% of total weight lost

Nausea Incidence:44% across 68 weeks

Primary Strength:

Extensive 6+ year long-term cardiovascular outcome safety data

TirzepatideOption B

Tirzepatide (Mounjaro/Zepbound)

Mechanism:Dual GIP / GLP-1 Receptor Agonist

Standard Dosing:2.5mg to 15.0mg weekly

Half-Life (T1/2):5 days (120 hours)

Muscle Loss Fraction:24% - 26% of total weight lost

Nausea Incidence:24% - 28% across 72 weeks

Primary Strength:

Superior total weight loss (up to 20.9% average reduction)

Head-to-Head Specification Matrix

Parameter	Semaglutide (Ozempic/Wegovy)	Tirzepatide (Mounjaro/Zepbound)	Clinical Impact
Mean Weight Loss at Maximum Dose	14.9% (STEP-1, 2.4mg)	20.9% (SURMOUNT-1, 15mg)	Tirzepatide yields roughly 40% greater total fat loss than Semaglutide.
Pharmacokinetic Half-Life	168 hours (7.0 days)	120 hours (5.0 days)	Semaglutide maintains steady-state suppression for a full 7-day cycle.
Muscle Loss Fraction without Resistance	Up to 39% of total weight lost	Approx. 25% of total weight lost	Both require reaching the leucine trigger (30g protein/meal) to prevent sarcopenia.
Severe Constipation Rate	24.2% reported in trials	17.1% reported in trials	Semaglutides longer half-life maintains more continuous colonic transit delay.

Interactive Diagnostic Calculator

Sarcopenia & Lean Mass Loss Risk Calculator

Evaluate your exact catabolic risk score, monthly muscle loss rate, and nitrogen floor.

Calculate Sarcopenia Risk →

Frequently Asked Clinical Questions (FAQ)

Which drug causes faster weight loss: Semaglutide or Tirzepatide?

Tirzepatide produces faster and greater overall weight loss. In head-to-head clinical studies (SURPASS-2), patients taking Tirzepatide lost an average of 5.5 kg more weight than those on Semaglutide.

Is nausea worse on Ozempic or Mounjaro?

Clinical trials report slightly lower rates of persistent severe nausea on Mounjaro/Zepbound compared to high-dose Wegovy (24% vs 44%). However, Mounjaro patients report higher rates of sulfur burps and rapid bowel transit.

Can you switch from Semaglutide to Tirzepatide?

Yes. Physicians routinely transition patients who hit weight loss plateaus on Semaglutide over to Tirzepatide. Because the molecules are different, patients usually transition to an equivalent intermediate dose rather than restarting at zero.